RV, K.; Asif, N.; Sethunath, A.N.; Thekkumkara, D.T.; Binu, D.; Krishna, G.; Sureshkumar, A.A.; Menon, A.M.; Thomas, S.S.; Abhinand, K.;
et al. Epigenetic Reprogramming by Mycobacterium tuberculosis Secretory Proteins: Implications for Pathogenesis and Therapy. Antibiotics 2026, 15, 557.
https://doi.org/10.3390/antibiotics15060557
AMA Style
RV K, Asif N, Sethunath AN, Thekkumkara DT, Binu D, Krishna G, Sureshkumar AA, Menon AM, Thomas SS, Abhinand K,
et al. Epigenetic Reprogramming by Mycobacterium tuberculosis Secretory Proteins: Implications for Pathogenesis and Therapy. Antibiotics. 2026; 15(6):557.
https://doi.org/10.3390/antibiotics15060557
Chicago/Turabian Style
RV, Krishna, Nafsiya Asif, Akash N. Sethunath, Deepak T. Thekkumkara, Devanandana Binu, Gowri Krishna, Aarsha A. Sureshkumar, Arjun M. Menon, Shwetha Susan Thomas, Kuniyil Abhinand,
and et al. 2026. "Epigenetic Reprogramming by Mycobacterium tuberculosis Secretory Proteins: Implications for Pathogenesis and Therapy" Antibiotics 15, no. 6: 557.
https://doi.org/10.3390/antibiotics15060557
APA Style
RV, K., Asif, N., Sethunath, A. N., Thekkumkara, D. T., Binu, D., Krishna, G., Sureshkumar, A. A., Menon, A. M., Thomas, S. S., Abhinand, K., Sasikumar, A., Padmakumar, S., Paniker, A., Babu, P., Kumar, G. B., Nair, B. G., & Madhavan, A.
(2026). Epigenetic Reprogramming by Mycobacterium tuberculosis Secretory Proteins: Implications for Pathogenesis and Therapy. Antibiotics, 15(6), 557.
https://doi.org/10.3390/antibiotics15060557
